Skip to main content
SleepCited

メラトニン 不眠症

A

合計44,766名の参加者を対象とした143件の研究(メタアナリシス13件、RCT 15件を含む)に基づく。143件中92件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Melatonin is supported by strong, extensive evidence as a supplement that may help with insomnia, making it one of the most well-researched natural sleep aids available.

  • 143 studies with 44,766 participants — among the largest evidence bases for any sleep supplement
  • 13 meta-analyses and 15 RCTs provide high-quality evidence
  • Recognized in multiple clinical practice guidelines and expert consensus statements
  • About 64% of studies show positive effects; results may vary by insomnia type and population

Key Study Findings

Other
A bedside-savior for insomnia and anxiety disorders: melatonin/buspirone hydrochloride compound oral fast-dissolving film.
Dose: melatonin + buspirone hydrochloride vs: None Outcome: product development for insomnia with anxiety 効果: None None

対象集団: patients with insomnia and anxiety disorders (formulation development)

review
Pediatric Insomnia.
Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) vs: Placebo 効果: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None
animal study
Compound Chaijin Jieyu Fang alleviates insomnia complicated with depression by reshaping actinobacteria to inhibit neuronal …
Dose: Compound Chaijin Jieyu Fang (CCJF) traditional Chinese medicine formula; dose not specified vs: Placebo 効果: None None
Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … 効果: None p<0.05

対象集団: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Controlled Clinical Trial n=24 2 weeks
D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.
Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) 効果: None None

対象集団: Rats with sodium arsenite-induced toxicity

review
Delayed sleep-wake phase disorder.
Dose: Scheduled melatonin, scheduled sleep-wake times, bright light therapy vs: Placebo 効果: None None

Key Statistics

237

研究数

54266

参加者数

Positive

A

グレード

Referenced Papers

Pediatrics in review 2026
Cleveland Clinic journal … 2025 12 件の引用
Handbook of clinical … 2025 10 件の引用
American journal of … 2025 6 件の引用
Chemico-biological interactions 2025 2 件の引用
CNS spectrums 2025 1 件の引用
JAAPA : official … 2025 1 件の引用
Paediatrics & child … 2025
The Cochrane database … 2025
Biologie aujourd'hui 2025
Psychiatry investigation 2024 24 件の引用
Current opinion in … 2024 12 件の引用
The Psychiatric clinics … 2024 11 件の引用
Neurourology and urodynamics 2024 7 件の引用
Sleep medicine 2024 6 件の引用
La Revue du … 2024
Current neuropharmacology 2023 38 件の引用
Journal of clinical … 2023 6 件の引用
Sleep and biological … 2023 6 件の引用
Child and adolescent … 2023 5 件の引用
Sub-cellular biochemistry 2023 2 件の引用
International journal of … 2022 107 件の引用
Neurologia 2022 78 件の引用
Archives of physiology … 2022 69 件の引用
Sleep medicine reviews 2022 48 件の引用
Neurologia 2022 47 件の引用
Current neuropharmacology 2022 40 件の引用
Journal of the … 2022 4 件の引用
Annual review of … 2021 149 件の引用
Progress in neuro-psychopharmacology … 2021 68 件の引用
Child and adolescent … 2021 61 件の引用
Chronobiology international 2021 47 件の引用
Combinatorial chemistry & … 2021 16 件の引用
Nutricion hospitalaria 2021 3 件の引用
Climacteric : the … 2020 97 件の引用
Neurotherapeutics : the … 2020 80 件の引用
Journal of psychiatric … 2020 52 件の引用
Current treatment options … 2020 29 件の引用
Sleep medicine clinics 2020 27 件の引用
The Medical letter … 2020 2 件の引用
Journal of pineal … 2019 124 件の引用
Journal of translational … 2019 93 件の引用
Dermatitis : contact, … 2019 7 件の引用
Journal of the … 2019 5 件の引用
The Medical letter … 2019
Sexual medicine reviews 2018 74 件の引用
Travel medicine and … 2018 27 件の引用
Ugeskrift for laeger 2018 2 件の引用
Nederlands tijdschrift voor … 2018
Journal of sleep … 2017 1691 件の引用
Neurological research 2017 331 件の引用
Nutrients 2017 301 件の引用
Continuum (Minneapolis, Minn.) 2017 132 件の引用
American family physician 2017 124 件の引用
Current treatment options … 2017 56 件の引用
FP essentials 2017 15 件の引用
Annual review of … 2016 557 件の引用
Clinical therapeutics 2016 328 件の引用
Chest 2016 109 件の引用
European heart journal. … 2016 77 件の引用
Trends in endocrinology … 2016 36 件の引用
Alcohol (Fayetteville, N.Y.) 2015 122 件の引用
Sleep medicine clinics 2015 75 件の引用
Current pharmaceutical design 2015 56 件の引用
European journal of … 2015 38 件の引用
Sleep medicine clinics 2015 30 件の引用
Drugs of today … 2015 15 件の引用
Medwave 2015 6 件の引用
Drug discovery today 2014 191 件の引用
The Cochrane database … 2014 131 件の引用
Child and adolescent … 2014 42 件の引用
Current signal transduction … 2014 41 件の引用
Anales de pediatria … 2014
Continuum (Minneapolis, Minn.) 2013 172 件の引用
Profiles of drug … 2013 26 件の引用
Journal of pineal … 2012 322 件の引用
Expert opinion on … 2012 116 件の引用
Expert opinion on … 2012 42 件の引用
Pharmacological reports : … 2011 99 件の引用
CNS neuroscience & … 2011 73 件の引用
Expert opinion on … 2011 22 件の引用
Anaesthesia and intensive … 2011 18 件の引用
Journal of pineal … 2011
Expert review of … 2010 58 件の引用
Letters in applied … 2010 57 件の引用
Current treatment options … 2010
Travel medicine and … 2009 101 件の引用
Seminars in neurology 2009 17 件の引用
Tidsskrift for den … 2009 6 件の引用
Drug and therapeutics … 2009
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 件の引用
Clinics in geriatric … 2008 53 件の引用
Sleep medicine reviews 2008 46 件の引用
Sleep medicine 2007 201 件の引用
The American journal … 2007 3 件の引用
The FEBS journal 2006 56 件の引用
Seminars in neurology 2004 16 件の引用
Journal of neuroendocrinology 2003 719 件の引用
Maturitas 2002 59 件の引用
Primary care 2002 43 件の引用
Revista de neurologia 2002 35 件の引用
Neuro endocrinology letters 2002
The Journal of … 2001 305 件の引用
Zeitschrift fur arztliche … 2001 3 件の引用
Journal of the … 2000 52 件の引用
Medical science monitor … 2000 11 件の引用
Reproduction, nutrition, development 1999 64 件の引用
Biological signals and … 1999 48 件の引用
Journal of the … 1999 24 件の引用
Current treatment options … 1999 23 件の引用
European journal of … 1999
Postgraduate medical journal 1998 17 件の引用
American family physician 1997
Journal of sleep … 1996 95 件の引用
Canadian journal of … 1984 22 件の引用
Microbiology and immunology 1982 41 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

上限量: No established UL; 5 mg typically considered maximum

研究で検討された用量

用量 期間 効果 N
melatonin + buspirone hydrochloride -- Neutral --
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) -- Positive --
Compound Chaijin Jieyu Fang (CCJF) traditional Chinese medicine formula; dose not specified -- Positive --
None -- Positive 55
10 mg/kg body weight 2 weeks Positive 24
Scheduled melatonin, scheduled sleep-wake times, bright light therapy -- Positive --
None -- Mixed --
None -- Positive 51

推奨摂取タイミング: 30-60 minutes before bed

Safety & Side Effects

報告されている副作用

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

既知の相互作用

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

耐容上限摂取量: No established UL; 5 mg typically considered maximum

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does メラトニン help with 不眠症?
Based on 237 studies with 54,266 participants, there is strong evidence from multiple clinical trials that メラトニン may support 不眠症 management. Our evidence grade is A (Strong Evidence).
How much メラトニン should I take for 不眠症?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of メラトニン?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for メラトニン and 不眠症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 237 peer-reviewed studies with 54,266 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。